Dialysis Patients.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Literacy (ability to read and write) Full alertness and orientation to time, place, and person to be able to answer the questions No history of hearing or visual impairments Having a personal mobile phone or any other device capable of running interactive videos, and the ability to use it A confirmed diagnosis of chronic kidney disease by a nephrologist and having an active medical record in the dialysis unit Absence of cognitive disorders Not using psychotropic medications Being in the age range of 18 to 65 years
Exclusion criteria
Exclusion criteria: Withdrawal from the study at any stage Failure to receive or watch the provided educational videos Transfer to a medical center outside the facilities Death of the participant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient Activation: In this study, patient activation refers to the average score obtained from the Patient Activation Measure (PAM) questionnaire developed by Hibbard and colleagues. Timepoint: The targeted outcomes will be assessed immediately before and after the completion of the training sessions, as well as one and three months there after. Method of measurement: The targeted outcomes will be assessed immediately after the completion of the training sessions, as well as one and three months there after. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Adherence: In this study, treatment adherence refers to the average score obtained from the End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ). Timepoint: The targeted outcomes will be assessed immediately before and after the completion of the training sessions, as well as one and three months there after. Method of measurement: End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ).;Patient Weight Changes: In this study, interdialytic weight gain (IDWG) will be measured by weighing patients immediately before connection to the dialysis machine and right after each hemodialysis session, following a standardized protocol. All measurements will be conducted using a calibrated digital medical scale (calibrated monthly). Patients will be weighed wearing a standard light dialysis gown, having emptied their bladder beforehand and refrained from eating or drinking. Additionally, all personal items (shoes, bags, jewelry) will be removed before weighing. Trained staff or researchers will record all measurements at fixed times (before starting and after finishing dialysis) with precision to ensure data consistency and reliable comparison of weight changes throughout the treatment period. Timepoint: The targeted outcomes will be assessed immediately before, after the completion of the training sessions, as well as one and three months there after. Method of measurement: Calibrated digital medical scale (with monthly calibration). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences